Principal Financial Group
CNCE

Principal Financial Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Principal Financial Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,845
Closed -$191K – 2336
2018
Q3 		$191K Buy
12,845
+249
+2% +$3.92K ﹤0.01% 2177
2018
Q2 		$212K Buy
+12,596
New +$245K ﹤0.01% 2152
2017
Q4 		– Sell
-118,600
Closed -$1.75M – 2279
2017
Q3 		$1.75M Buy
118,600
+3,500
+3% +$50.8K ﹤0.01% 1758
2017
Q2 		$1.61M Hold
115,100
– – ﹤0.01% 1773
2017
Q1 		$1.96M Hold
115,100
– – ﹤0.01% 1731
2016
Q4 		$1.18M Buy
115,100
+1,416
+1% +$12.9K ﹤0.01% 1788
2016
Q3 		$1.15M Buy
113,684
+984
+0.9% +$10.8K ﹤0.01% 1751
2016
Q2 		$1.27M Sell
112,700
-2,900
-3% -$36.9K ﹤0.01% 1725
2016
Q1 		$1.58M Hold
115,600
– – ﹤0.01% 1667
2015
Q4 		$2.19M Sell
115,600
-82,100
-42% -$1.78M ﹤0.01% 1616
2015
Q3 		$3.71M Buy
197,700
+4,600
+2% +$78.2K 0.01% 1465
2015
Q2 		$2.88M Buy
193,100
+18,200
+10% +$277K ﹤0.01% 1606
2015
Q1 		$2.65M Hold
174,900
– – ﹤0.01% 1596
2014
Q4 		$2.33M Sell
174,900
-3,500
-2% -$45.2K ﹤0.01% 1651
2014
Q3 		$2.25M Sell
178,400
-55,600
-24% -$539K ﹤0.01% 1628
2014
Q2 		$2.36M Buy
234,000
+125,485
+116% +$1.21M ﹤0.01% 1648
2014
Q1 		$1.46M Buy
+108,515
New +$1.53M ﹤0.01% 1718

Other funds holding CNCE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group's CNCE Position: Q4 2018 in Review

Principal Financial Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2018, closing a stake of 12,845 shares — an estimated $191K sold.

Principal Financial Group first reported a position in CNCE in Q1 2014 and held it in 17 quarters. The position peaked at $3.71M in Q3 2015. 93 funds tracked by Wall St. Rank hold CNCE as of Q4 2018.

  • Principal Financial Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Principal Financial Group sold 12,845 Concert Pharmaceuticals, Inc. shares in Q4 2018, an estimated $191K.
  • Principal Financial Group first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 17 quarters.
  • Principal Financial Group's Concert Pharmaceuticals, Inc. position peaked at $3.71M in Q3 2015.
  • 93 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2018.

Based on Principal Financial Group's 13F filing for Q4 2018, filed 14 Feb 2019.